• Mikroskopaufnahme

Welcome to the Hudecek Lab – The home of CAR T

Our research

We are developing novel personalized immune-based cancer treatments that involve reprogramming of the patient’s own immune system cells which are then used to target and destroy cancer cells.

Our approach

We are equipping T cells (white blood cells) with a biosensor (chimeric antigen receptor, CAR) to help them detect and eliminate cancer cells.
 

Latest publications

Jaeckel E, Friedman SL, Hudecek M, Protzer U. 
Chimeric Antigen Receptor (CAR) T-cell Therapy: Engineering Immune Cells To Treat Liver Diseases. 
J Hepatol. 2025 Jun 20:S0168-8278(25)02274-3
Go to publication

De Angelis B, D'Amore ML, Lecot P, Neininger K, Lorrain M, Gambotti L, Dreuillet C, Courcault E, Chatterjee S, Delgado J, Galy A, Franz P, Rodriguez-Madoz JR, Cabrerizo Y, Richter A, Girvalaki C, Noviello M, Tassi E, Sanges C, Luu M, Hudecek M, Kremer A, Locatelli F, Negre H, Quintarelli C. 
European survey on CAR T-Cell analytical methods from apheresis to post-infusion immunomonitoring. 
Front Immunol. 2025 Apr 24;16:1567582
Go to publication

Hinckley-Boned A, Barbero-Jiménez C, Tristán-Manzano M, Maldonado-Perez N, Hudecek M, Justicia-Lirio P, Martin F. 
Tailoring CAR surface density and dynamics to improve CAR-T cell therapy.
J Immunother Cancer. 2025 Apr 29;13(4):e010702
Go to publication

Wegner VD, Feile A, Alb M, Hudecek M, Hewitt P, Mosig AS. 
Short-Chain Fatty Acids Modulate Anti-ROR1 CAR T-Cell Function and Exhaustion in an Intestinal Adenocarcinoma-on-Chip Model.
Adv Healthc Mater. 2025 May;14(13):e2405003
Go to publication

Peter J, Toppeta F, Trubert A, Danhof S, Hudecek M, Däullary T. 
Multi-Targeting CAR-T Cell Strategies to Overcome Immune Evasion in Lymphoid and Myeloid Malignancies. 
Oncol Res Treat. 2025;48(5):265-279
Go to publication

Dragon AC, Bonifacius A, Lienenklaus S, Verboom M, Gerhards JP, Ius F, Hinze C, Hudecek M, Figueiredo C, Blasczyk R, Eiz-Vesper B. Depletion of alloreactive B cells by drug-resistant chimeric alloantigen receptor T cells to prevent transplant rejection. 
Mol Ther. 2025 Mar 5;33(3):1031-1047
Go to publication

Fleischer A, Kurth S, Duell J, Topp M, Strunz PP, Mersi J, Rasche L, Sanges C, Hudecek M, Einsele H, Maatouk I. 
Neuropsychiatric manifestations following chimeric antigen receptor T cell therapy for cancer: a systematic review of clinical outcomes and management strategies. 
J Immunother Cancer. 2024 Dec 22;12(12):e009174
Go to publication

Jacobs JJL, Beekers I, Verkouter I, Richards LB, Vegelien A, Bloemsma LD, Bongaerts VAMC, Cloos J, Erkens F, Gradowska P, Hort S, Hudecek M, Juan M, Maitland-van der Zee AH, Navarro-Velázquez S, Ngai LL, Rafiq QA, Sanges C, Tettero J, van Os HJA, Vos RC, de Wit Y, van Dijk S. 
A data management system for precision medicine.
PLOS Digit Health. 2025 Jan 9;4(1):e0000464
Go to publication

Gehrke L, Gonçalves VDR, Andrae D, Rasko T, Ho P, Einsele H, Hudecek M, Friedel SR. 
Current Non-Viral-Based Strategies to Manufacture CAR-T Cells. 
Int J Mol Sci. 2024 Dec 21;25(24):13685
Go to publication

Alb M, Reiche K, Rade M, Sewald K, Loskill P, Cipriano M, Maulana TI, van der Meer AD, Weener HJ, Clerbaux LA, Fogal B, Patel N, Adkins K, Lund E, Perkins E, Cooper C, van den Brulle J, Morgan H, Rubic-Schneider T, Ling H, DiPetrillo K, Moggs J, Köhl U, Hudecek M. 
Novel strategies to assess cytokine release mediated by chimeric antigen receptor T cells based on the adverse outcome pathway concept.
J Immunotoxicol. 2024 Oct;21(sup1):S13-S28
Go to publication


  • Logo of the Comprehensive Cancer Center Mainfranken
  • Logo des Vereins Forschung hilft
  • Logo of the Bayerische Akademie der Wissenschaften
  • Logo of the Bundesministerium für Bildung und Forschung
  • Logo der Deutschen Forschungsgemeinschaft DFG
  • Logo of the project H2020
  • Logo of Hilfe im Kampf gegen den Krebs e.V.
  • Logo of the Interdisziplinäres Zentrum für Klinische Forschung
  • Logo of the José Carreras foundation
  • Logo of Deutsche Krebshilfe
  • Logo of m4 Personalisierte Medizin e.V.
  • Logo of Marie Skłodowska-Curie Actions
  • Logo of Myeloma Crowd
  • Logo der Helmholtz-Gemeinschaft Deutscher Forschungszentren

Contact person

Portraitfoto von Univ.-Prof. Dr. med. Michael Hudecek

Univ.-Prof. Dr. med.
Michael Hudecek

Director and Research Group Leader Translational CAR-T Research Program

Address

Department of Internal Medicine II | Oberdürrbacher Straße 6 | 97080 Würzburg | Germany

schließen